司他夫定 (Zerit)

Stavudine

生产企业：Bristol myers squibb co, Aurobindo pharma ltd，另有 5 家

Stavudine is a dideoxynucleoside used in the treatment of HIV infection.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Stavudine is a dideoxynucleoside used in the treatment of HIV infection.

作用机制

Stavudine inhibits the activity of HIV-1 reverse transcriptase (RT) both by competing with the natural substrate dGTP and by its incorporation into viral DNA.

适应症

For the treatment of human immunovirus (HIV) infections.

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium
US 7700576 B2申请人: LATVIAN INST OF ORGANIC SYNTHE优先权: 2005
CN
US
3 件公开
Novel Method for the Preparation of Stavudine Polymorphic Form I and Form II
US 2012322996 A1申请人: DI LERNIA GIANLUCA优先权: 2006
CN
US
2 件公开
Compositions for use in treating parkinson's disease and related disorders
US 10471025 B2申请人: TECHNOPHAGE INVESTIG E DESENVOLVIMENTO EM BIOTECNOLOGIA SA优先权: 2015
CN
US
2 件公开
Process for preparing 5'-acetylstavudine
US 2001039342 A1申请人: BERTOLINI GIORGIO优先权: 2000
US
2 件公开
Sustained release beadlets containing stavudine
US 7135465 B2申请人: BRISTOL MYERS SQUIBB CO优先权: 2001
US
2 件公开
Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV
US 7615542 B2申请人: UNIV GEORGIA RES FOUND优先权: 2005
US
2 件公开
Process for the large scale production of Stavudine
US 8026356 B2申请人: MATRIX LAB LTD优先权: 2005
US
2 件公开
Stavudine Polymorphic Form 1 process
US 2003225279 A1申请人: BRISTOW SIMON CRAWFORD优先权: 2002
US
Stavudine sustained release tablet and its preparing process
CN 1634116 A申请人: NORTHEAST GENERAL PHARMACEUTIC优先权: 2004
CN
Oral preparation of quick releasing stavudine, and producing method
CN 1695632 A申请人: MINGXIN HI TEH DEV CO LTD BEIJ优先权: 2005
CN

药物

司他夫定 (Zerit)

概览

作用机制

适应症

相关疾病

专利